Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 15,199

Document Document Title
WO/2018/222781A3
The invention is composition and methods that restore balance to the stress-related steroidal hormone cascade. Upon co-administration, the compounds of the invention restore balance to the cascade and promote or restore normal function i...  
WO/2020/070088A1
The present invention provides novel compounds having the general formula (Formula I) : wherein R1 to R6, G1, G2, A1 to A4 and m are as described herein, compositions including the compounds and methods of using the compounds.  
WO/2020/044119A3
Described herein are cannabinoid formulations in combination with lavender and/or a lavender extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need the...  
WO/2020/071550A1
The present invention provides a novel CDK8 inhibitor. The present invention relates to: a compound represented by general formula (I) (wherein the symbols are as defined in the description) or a pharmaceutically acceptable salt thereof;...  
WO/2020/061703A1
The present disclosure relates to cannabinoid-containing product for human consumption having an improved taste profile and to methods of manufacturing same. The present disclosure also relates to a process for making a cannabinoid-conta...  
WO/2020/061687A1
According to embodiments herein, pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions are provided. More specifically, a cannabis-based pharmaceutical composition and methods of ...  
WO/2020/059768A1
The present invention provides a halogen compound that can be advantageously used for production of a 1,1-disubstituted hydrazine compound and preparation of a polymerizable compound. A compound according to the present invention is repr...  
WO/2020/058339A1
Disclosed herein are novel coumarin-based reagents, e.g. linkers, and conjugates including one or more of the disclosed coumarin-based reagents. In some embodiments, the presence of a coumarin moiety within the coumarin-based reagents en...  
WO/2020/052774A1
The application provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DNA) inhibitors.  
WO/2020/053353A1
The invention relates to a method for producing S-arylthiocarbamates of general formula (I) by means of an electrochemically induced rearrangement of an O-arylthiocarbamate of general formula (II).  
WO/2020/053249A1
The present invention provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DMA) inhibitors.  
WO/2020/050462A1
The present invention relates to a naphthopyrone derivative and a composition comprising, as an active ingredient, a Cassia obtusifolia shoot extract including the naphthopyrone derivative. A composition according to an aspect of the pre...  
WO/2020/047668A1
Provided herein are Myc-Max inhibitory compounds having the structure of Formula (I) and compositions thereof for use in the treatment of cancer. In particular, the Myc-Max inhibitory compounds may be useful for the treatment of cancers ...  
WO/2020/051370A1
The identification and confirmation of 3 HTS hits with in vitro MEKK2 inhibitory activity using the MEKK2 ATPase HTS assay is shown. Preliminary SAR studies identified additional compounds for inhibiting MEKK2. Use of these compounds for...  
WO/2020/051322A1
The present disclosure relates to a method of treating at least one condition selected from Cytokine Release Syndrome (CRS), Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS), cancer-related cognitive impairment, Infusion Re...  
WO/2020/044121A1
Described herein are cannabinoid formulations in combination with phenylalanine for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturin...  
WO/2020/041871A1
This application is directed to the use of a ketogenic agent, such as 1,3-butanediol, R-β-hydroxybutyl-R-β-hydroxybutyrate, or triheptanoin, in the treatment of an individual having a lysosomal storage disease, including Pompe disease....  
WO/2020/044123A1
Described herein are cannabinoid formulations in combination with Boswellia extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufact...  
WO/2020/041860A1
An aqueous alkaline composition comprising a cannabinoid which may be cannabidiol (CBD) used alone or in combination with other cannabinoids. An alkalizing agent which comprises pico size carbon particles is present in the composition, i...  
WO/2020/046822A1
A method for purification and separation of cannabinoids, such as cannabidiol and tetrahydrocannabinol, e.g., from dried hemp and cannabis leaves can use a continuous simulated moving bed process, a batch column chromatography method, or...  
WO/2020/044116A1
Described herein are cannabinoid formulations in combination with curcumin for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing ora...  
WO/2020/044118A1
Described herein are cannabinoid formulations for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof.  
WO/2020/041877A1
Systems and methods of extracting compounds from botanical matter are provided. The system includes: a solvent source; an extraction vessel which receives botanical matter from which compounds, including at least one target compound are ...  
WO/2020/037413A1
The present disclosure relates to a cannabinoid based emulsification system for infusing a non-aqueous composition with a cannabinoid, the emulsification system comprising: a) at least one cannabinoid in a carrier oil; b) a plurality of ...  
WO/2020/040582A1
The present invention relates to a novel benzopyran derivative or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising same as an effective ingredient. Having no influence on the complex structure of HSP...  
WO/2020/037410A1
The present disclosure relates to a cannabis-infused product, comprising an emulsion containing a cannabinoid profile including one or more cannabinoid, wherein the emulsion is a nanoemulsion. The disclosure also relates to methods of ma...  
WO/2020/037409A1
The present disclosure relates to a cannabis-infused product comprising a cannabinoid profile including one or more cannabinoid, a first composition for controlling onset of the cannabinoid profile and a second composition for extending ...  
WO/2020/037412A1
The present disclosure relates to a cannabinoid based dry or aqueous self-emulsification system for infusing a composition with a cannabinoid. The self-emulsification system comprises: a) at least one cannabinoid in a carrier oil; b) a p...  
WO/2020/037402A1
A dosage device that includes a cannabinoid-containing substance enables controlled addition of the cannabinoid-containing substance to a liquid to produce a cannabinoid-containing liquid for ingestion. In an embodiment, such a dosage de...  
WO/2020/037408A1
The present disclosure relates to a cannabis-infused product comprising a cannabinoid profile including one or more cannabinoid, a first composition for controlling onset of the cannabinoid profile and a second composition for controllin...  
WO/2020/035601A1
The present invention relates to a process for the production of chromanol and 2-methyl-1,4-naphthoquinone derivatives, more specifically to a process for preparing a compound of the general formula (I) or (II) wherein the variables are ...  
WO/2020/035058A1
Disclosed are a class of pharmaceutical compounds for treating liver diseases and application thereof. In particular, said pharmaceutical compounds are compounds as represented by general formula (I), optical isomers, or pharmaceutically...  
WO/2020/035604A1
The present invention relates to a process for the production of chromanol derivatives, more specifically to a process for preparing a compound of the general formula I wherein R1, R2 and R3 independently of each other are selected from ...  
WO/2020/035600A1
The present invention relates to a process for the production of chromanol derivatives, more specifically to a process for preparing a compound of the general formula (I) wherein R1, R2 and R3 independently of each other are selected fro...  
WO/2019/008537A9
There is provided a medical compound comprising a synthetic flavone derivative, according to the formula (I) with allotment in position C-3 of a group as shown below: Formula (I) wherein at least two of R2-R6 a re H, and the remaining ar...  
WO/2020/028991A1
The invention relates to methods for producing botanical extracts comprising cannabinoids and terpenes using cold extraction with highly polyunsaturated lipid solvents. These methods allow for the extraction of cannabinoids and terpenes ...  
WO/2020/032913A1
Disclosed is a novel, simple, scalable and environment friendly process for the synthesis of Oroxylin A from Baicalin. Baicalm is esterified to obtain a methyl ester which is further selectively methylated to provide Oroxylin A gluciiron...  
WO/2020/028992A1
The invention relates to methods of producing extracts from cannabis plant material, where the extracts comprise cannabinoids and terpenes. The methods comprise extracting fresh or dried plant material with a cold organic solvent. The me...  
WO/2020/031179A1
The present invention provides simple synthetic routes for the preparation of cannabinoid compounds such as CBD, CBDV, THC, THCV, CBN, HU-308, CBG, CBC, and derivatives thereof, which are stereoselective and provide the desired cannabino...  
WO/2020/028988A1
A method is for use with a treatment regime that includes the exposure of a patient to THC. The method comprises the step of administering Theanine to the patient. The Theanine can be L-Theanine. The treatment regime can involve a plural...  
WO/2020/033859A1
Various aspects of this disclosure relate to methods to lower the activation energy of the cannabinoid decarboxylation reaction by performing the decarboxylation reaction in the gas phase.  
WO/2020/024977A1
The present invention in particular relates to a class of compounds for treating nervous system diseases, the compounds are the compound as shown by formula (I) or a stereoisomer, a geometric isomer, a tautomer, a solvate, a metabolite, ...  
WO/2020/024099A1
The present invention discloses a cyclopentadienyl [c] chromium compound and a preparation method therefor wherein a cationic rare earth compound [Ln(CH)3CN) 9] 3+[(AlCl 4) 3] 3–•CH 3 CN is used as a catalyst, and a 2-naphthol is use...  
WO/2020/027206A1
This composition includes a polyphenol compound (B) and a solvent, wherein the polyphenol compound (B) is at least one selected from among a compound represented by formula (1) and a resin having a structure represented by formula (2). (...  
WO/2020/025639A1
The present disclosure provides compositions that include tetra-O-methylscutellarein, hexamethoxyquercetagetin, or mixtures or combinations thereof, as well as their use as sweeteners or sweetness enhancers.  
WO/2020/024100A1
The present invention discloses a method for preparing a cyclopentadienyl [c] chromium compound wherein a cationic rare earth compound [Ln(CH)3CN) 9] 3+[(A1C1 4) 3] 3–•CH 3 CN is used as a catalyst, and methyl thiophenol is used as a...  
WO/2020/024056A1
The present technology generally relates to a composition for topical administration or for oral administrations. The composition comprises at least one cannabinoid and at least one absorbable material. In some instances, the at least on...  
WO/2020/028396A1
The present invention relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, and providing a probe selected from the group consisting of coumarin-d...  
WO/2020/019289A1
The present invention relates to a novel rhodamine dye and an application thereof against pathogenic bacteria. In particular, the present invention relates to a compound represented by the following formula A. In the formula, X- and R1-R...  
WO/2020/021709A1
Provided is a method for decomposing a flavonoid glycoside, wherein a flavonoid glycoside-containing raw material is hydrothermally treated to decompose a flavonoid glycoside into a flavonoid.  

Matches 201 - 250 out of 15,199